January 9, 2018 / 5:30 AM / 9 months ago

BRIEF-Shenzhen Neptunus Bioengineering gets approval for conducting phase II trials for polydatin injection in U.S.

Jan 9(Reuters) - Shenzhen Neptunus Bioengineering Co Ltd

* Says it received approval for conducting phase II trials for polydatin injection in the U.S.

Source text in Chinese: goo.gl/ben7y1

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below